Pencho Georgiev

1.7k total citations
30 papers, 333 citations indexed

About

Pencho Georgiev is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Pencho Georgiev has authored 30 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 17 papers in Hematology and 10 papers in Rheumatology. Recurrent topics in Pencho Georgiev's work include Hemophilia Treatment and Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Eosinophilic Disorders and Syndromes (8 papers). Pencho Georgiev is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Eosinophilic Disorders and Syndromes (8 papers). Pencho Georgiev collaborates with scholars based in Bulgaria, France and United Kingdom. Pencho Georgiev's co-authors include Toshko Lissitchkov, John Pasi, Liana Gercheva, Margaret V. Ragni, Tim Mant, Pratima Chowdary, Sigurd Knaub, L. Rusen, Jerzy Windyga and J. Bichler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Pencho Georgiev

29 papers receiving 326 citations

Peers

Pencho Georgiev
Peter A. te Boekhorst Netherlands
Soo-Young Choi South Korea
José Antonio Queizán Spain
Klaudia Bagienski Austria
Wanke Zhao United States
Nicola Long United States
Patrick Löffeld Germany
Céline Mouton Belgium
Mónica Del Rey Spain
F. Giles United States
Peter A. te Boekhorst Netherlands
Pencho Georgiev
Citations per year, relative to Pencho Georgiev Pencho Georgiev (= 1×) peers Peter A. te Boekhorst

Countries citing papers authored by Pencho Georgiev

Since Specialization
Citations

This map shows the geographic impact of Pencho Georgiev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pencho Georgiev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pencho Georgiev more than expected).

Fields of papers citing papers by Pencho Georgiev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pencho Georgiev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pencho Georgiev. The network helps show where Pencho Georgiev may publish in the future.

Co-authorship network of co-authors of Pencho Georgiev

This figure shows the co-authorship network connecting the top 25 collaborators of Pencho Georgiev. A scholar is included among the top collaborators of Pencho Georgiev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pencho Georgiev. Pencho Georgiev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Georgiev, Pencho, et al.. (2024). Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors. Diagnostics. 14(23). 2672–2672. 1 indexed citations
2.
Pipe, Steven W., Toshko Lissitchkov, Pencho Georgiev, et al.. (2024). Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B. Blood Advances. 9(5). 1147–1158. 2 indexed citations
3.
Cappellini, Maria Domenica, Alì Taher, Vip Viprakasit, et al.. (2023). Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover Study. Blood. 142(Supplement 1). 3849–3849. 1 indexed citations
4.
5.
Pasi, John, Toshko Lissitchkov, Vasily Mamonov, et al.. (2021). Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort. Journal of Thrombosis and Haemostasis. 19(6). 1436–1446. 69 indexed citations
6.
Négrier, Claude, MV Ragni, Inga Hegemann, et al.. (2021). Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study. Hämostaseologie. 1 indexed citations
7.
Georgiev, Pencho, et al.. (2020). Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities. SHILAP Revista de lepidopterología. 62(2). 265–270. 1 indexed citations
8.
Prezotti, A., John Pasi, Claude Négrier, et al.. (2020). PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA. Hematology Transfusion and Cell Therapy. 42. 74–75. 3 indexed citations
9.
Pettengell, Ruth, Monika Długosz‐Danecka, David Andorsky, et al.. (2019). Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306). British Journal of Haematology. 188(2). 240–248. 12 indexed citations
10.
Gisslinger, Heinz, Christoph Klade, Pencho Georgiev, et al.. (2019). Ropeginterferon Alfa-2b versus Standard Therapy for Polycythaemia Vera; a Randomised, Controlled, Phase III Trial. SSRN Electronic Journal. 5 indexed citations
11.
Ragni, Margaret V., Pencho Georgiev, Michael Desmond Creagh, et al.. (2018). The Role of Antithrombin Lowering in Patients with Hemophilia: Hemostatic Control Pre- and Post-Fitusiran Dosing Interruption. Blood. 132(Supplement 1). 2477–2477. 2 indexed citations
12.
Gisslinger, Heinz, Christoph Klade, Pencho Georgiev, et al.. (2018). Evidence for Superior Efficacy and Disease Modification after Three Years of Prospective Randomized Controlled Treatment of Polycythemia Vera Patients with Ropeginterferon Alfa-2b Vs. HU/BAT. Blood. 132(Supplement 1). 579–579. 14 indexed citations
13.
14.
Négrier, Claude, Margaret V. Ragni, Pencho Georgiev, et al.. (2017). Perioperative Management in Patients with Hemophilia Receiving Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia. Blood. 130. 2366–2366. 9 indexed citations
15.
Lissitchkov, Toshko, L. Rusen, Pencho Georgiev, et al.. (2017). PK‐guided personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in adults with severe haemophilia A. Haemophilia. 23(5). 697–704. 43 indexed citations
16.
17.
18.
Georgiev, Pencho, Tim Mant, Toshko Lissitchkov, et al.. (2016). A Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or B. Queen Mary Research Online (Queen Mary University of London). 4 indexed citations
19.
20.
Belada, David, Pencho Georgiev, Shaker R. Dakhil, et al.. (2016). Pixantrone–Rituximab Versus Gemcitabine–Rituximab In Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma. Future Oncology. 12(15). 1759–1768. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter A. te Boekhorst Breakdown of academic impact, for papers by Soo-Young Choi Breakdown of academic impact, for papers by José Antonio Queizán Breakdown of academic impact, for papers by Klaudia Bagienski Breakdown of academic impact, for papers by Wanke Zhao Breakdown of academic impact, for papers by Nicola Long Breakdown of academic impact, for papers by Patrick Löffeld Breakdown of academic impact, for papers by Céline Mouton Breakdown of academic impact, for papers by Mónica Del Rey Breakdown of academic impact, for papers by F. Giles
Rankless by CCL
2026